Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Research Boom Beckons Wellcome Trust With £30 Million Fund

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Prospects of conducting successful biomedical research at low costs in India is attracting investments not just from multinational companies, but also from some of the world's largest charitable institutions. Wellcome Trust, U.K.'s largest charitable non-governmental organization for biomedical research announced a £30 million India-dedicated fund to identify and grow new drug innovations

You may also be interested in...

Indian Govt. Plans Booster Dose For Indian Biotech Industry Through Cost-sharing Scheme

MUMBAI - In a move that could give a major boost to small Indian biotechnology companies, the Indian government's department of biotechnology has announced the Biotechnology Industry Partnership Program

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts